We are live on ! Find out more
ROIV icon

Roivant Sciences

110 hedge funds and large institutions have $3.29B invested in Roivant Sciences in 2022 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 10

228% more call options, than puts

Call options by funds: $2.88M | Put options by funds: $876K

176% more capital invested

Capital invested by funds: $1.19B → $3.29B (+$2.1B)

120% more funds holding in top 10

Funds holding in top 10: 511 (+6)

118% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 17

41% more funds holding

Funds holding: 78110 (+32)

4.11% more ownership

Funds ownership: 52.67%56.78% (+4.1%)

Holders
110
Holders Change
+32
Holders Change %
+41.03%
% of All Funds
1.77%
Holding in Top 10
11
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+120%
% of All Funds
0.18%
New
42
Increased
37
Reduced
17
Closed
10
Calls
$2.88M
Puts
$876K
Net Calls
+$2M
Net Calls Change
+$1.66M
Name Holding Trade Value Shares
Change
Change in
Stake
Point72 Asset Management
26
Point72 Asset Management
Connecticut
$4.61M +$3.21M +576,800 New
Charles Schwab
27
Charles Schwab
California
$4.48M +$218K +39,268 +8%
ACM
28
Atika Capital Management
New York
$4.47M +$3.12M +560,000 New
PIM
29
Platinum Investment Management
Australia
$4.44M +$278K +50,037 +10%
Goldman Sachs
30
Goldman Sachs
New York
$4.17M +$1.8M +322,742 +163%
Invesco
31
Invesco
Georgia
$4M +$2.7M +485,917 +3,268%
AA
32
ALPS Advisors
Colorado
$3.93M +$2.74M +491,724 New
MIM
33
Monashee Investment Management
Massachusetts
$3.76M +$2.61M +470,000 New
Northern Trust
34
Northern Trust
Illinois
$3.18M +$566K +101,800 +34%
Rafferty Asset Management
35
Rafferty Asset Management
New York
$2.93M +$1.21M +218,279 +147%
Morgan Stanley
36
Morgan Stanley
New York
$2.75M +$1.69M +303,340 +737%
UBS AM
37
UBS AM
Illinois
$2.61M +$298K +53,493 +20%
SSA
38
Schonfeld Strategic Advisors
New York
$2.42M +$1.69M +303,215 New
State of Wisconsin Investment Board
39
State of Wisconsin Investment Board
Wisconsin
$2.26M -$462 -83 -0%
EWM
40
Edge Wealth Management
New York
$2.09M
CS
41
Credit Suisse
Switzerland
$2M +$209K +37,644 +18%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$1.96M +$34.5K +6,202 +3%
Bank of America
43
Bank of America
North Carolina
$1.71M +$1.01M +181,393 +561%
Voloridge Investment Management
44
Voloridge Investment Management
Florida
$1.6M +$1.12M +200,648 New
DekaBank Deutsche Girozentrale
45
DekaBank Deutsche Girozentrale
Germany
$1.5M +$1.11M +200,000 New
Tudor Investment Corp
46
Tudor Investment Corp
Connecticut
$1.37M -$1.01M -182,351 -51%
Alyeska Investment Group
47
Alyeska Investment Group
Illinois
$1.35M +$939K +168,800 New
JF
48
Jump Financial
Illinois
$1.33M +$925K +166,204 New
UBS Group
49
UBS Group
Switzerland
$1.29M +$896K +161,012 New
Bank of New York Mellon
50
Bank of New York Mellon
New York
$1.06M +$78.7K +14,145 +12%

ROIV Hedge Fund Activity: Q4 2022 in Review

110 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q4 2022, worth a combined $3.29B — up 176% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new ROIV positions and 10 closed out — a net gain of 32 holders — while 37 added to existing stakes and 17 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $146M. The largest seller was QVT Financial, cutting an estimated $38.1M.

  • 110 institutional investors held Roivant Sciences (ROIV) as of Q4 2022, up from 78 in Q3 2022.
  • Funds reported $3.29B of Roivant Sciences stock for Q4 2022, up 176% quarter-over-quarter.
  • 42 funds opened new Roivant Sciences positions in Q4 2022 and 10 closed out, a net change of +32 holders.
  • The largest Roivant Sciences buyer in Q4 2022 was Fidelity Investments, an estimated $146M added.
  • The largest Roivant Sciences seller in Q4 2022 was QVT Financial, an estimated $38.1M sold.

Based on aggregated 13F filings for Q4 2022.